氯胺酮在神经外科中的历史回顾
本文回顾氯胺酮(ketamine)自1962年合成、1970年获FDA批准以来的神经外科应用史,梳理其因起效快、无需插管、苏醒平稳而受儿科神经外科青睐,以及因对颅内压(ICP)的早期担忧等因素致使用减少的历程,并讨论其安全性误解、对ICP的影响与当前应用。
要点
- 氯胺酮起效快、无需插管、苏醒平稳,曾在儿科神经外科受青睐
- 早期对氯胺酮升高颅内压(ICP)的担忧影响了其在神经外科的使用
- 重新评估氯胺酮的历史与作用可能改善神经重症预后
核心结论
- 重新评估氯胺酮的历史与作用,可能改善神经重症监护的结局,并提升对其神经外科潜力的认识。
研究设计与样本
- 本文为历史回顾类研究,梳理氯胺酮的合成、获批与神经外科临床应用演变,并讨论其安全性误解、对颅内压(ICP)的影响及当前神经外科应用。
主要发现
- 氯胺酮为短效麻醉药,1962年首次合成,是苯环己哌啶(PCP)的更安全衍生物。
- 氯胺酮1970年获FDA批准,在越南战争期间被广泛使用。
- 氯胺酮因起效快、无需插管、苏醒平稳而在儿科神经外科受青睐,并提出「分离麻醉」概念。
- 新型麻醉药出现、早期对氯胺酮升高颅内压(ICP)的担忧及与娱乐性用药的关联,导致其在神经外科临床使用下降。
临床怎么用
- 文中提出重新评估氯胺酮的历史与作用,可能改善神经重症监护结局,并提升对其神经外科潜力的认识。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ketamine, a short-acting anesthetic first synthesized in 1962, has long been surrounded by controversy, particularly regarding its use in neurosurgery. The rise in elective surgeries in the early 20th century spurred the development of new anesthetics. Phencyclidine (PCP) was created, which was effective but caused psychotic features. In response, ketamine, a safer PCP derivative was synthesized. Approved by the FDA in 1970, ketamine was widely used during the Vietnam War and gained favor in pediatric neurosurgery due to its rapid onset, lack of intubation requirement, and smooth recovery. It introduced the concept of "dissociative anesthesia." However, the emergence of newer anesthetics, early concerns about ketamine raising intracranial pressure (ICP), and its association with recreational drug use led to a decline in clinical neurosurgical use. This study explores ketamine's history, misconceptions about its safety, its effects on ICP, and its current neurosurgical applications. Reevaluating ketamine's history and its role could improve outcomes in neurological critical care and lead to a greater awareness that is essential to understanding its potential in neurosurgery.
引用
- Sinclair AL, Jelkin G, Zucca B, et al. Ketamine in neurosurgery: a historical perspective. J Neurosurg. 2026. PMID: 42497458. doi:10.3171/2026.2.JNS251845
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。